Alvimopan
- Generic Name
- Alvimopan
- Brand Names
- Entereg
- Drug Type
- Small Molecule
- Chemical Formula
- C25H32N2O4
- CAS Number
- 156053-89-3
- Unique Ingredient Identifier
- Q153V49P3Z
Overview
Alvimopan is a peripherally acting μ opioid antagonist. It is used to avoid postoperative ileus following small or large bowel resection and accelerates the gastrointestinal recovery period.
Background
Alvimopan is a peripherally acting μ opioid antagonist. It is used to avoid postoperative ileus following small or large bowel resection and accelerates the gastrointestinal recovery period.
Indication
用于手术以及使用阿片类药物导致的胃肠功能紊乱，特发性便秘以及肠易激综合症等。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
ALVIMOPAN
Manufacturer:Par Pharmaceutical, Inc.
Route:ORAL
Strength:12 mg in 1 1
Approved: 2023/04/26
NDC:0254-3012
Alvimopan
Manufacturer:Actavis Pharma, Inc.
Route:ORAL
Strength:12 mg in 1 1
Approved: 2021/01/31
NDC:0591-2312
Alvimopan
Manufacturer:Golden State Medical Supply, Inc.
Route:ORAL
Strength:12 mg in 1 1
Approved: 2024/02/08
NDC:51407-870
Alvimopan
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:ORAL
Strength:12 mg in 1 1
Approved: 2022/10/24
NDC:0054-0668
Entereg
Manufacturer:Merck Sharp & Dohme LLC
Route:ORAL
Strength:12 mg in 1 1
Approved: 2022/05/11
NDC:67919-020
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath